Ritipenem is a penem class antimicrobial agent. Ritipenem is manufactured by Tanabe Seiyaku in the ritipenem acoxil prodrug form, which can be taken orally . It is not FDA approved in the United States as of 2008.
References
- Eiland III EH, Gatlin D (October 2008). "Forecast of antibiotic development in an era of increasing bacterial resistance". Journal of Pharmacy Practice. 21 (5): 313–8. doi:10.1177/0897190008318499. S2CID 71894409.
You must be logged in to post a comment.